Concepts (239)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Nephrectomy | 19 | 2021 | 1049 | 5.440 |
Why?
|
Lymph Node Excision | 16 | 2022 | 1248 | 4.670 |
Why?
|
Urinary Bladder Neoplasms | 13 | 2023 | 2229 | 3.430 |
Why?
|
Carcinoma, Transitional Cell | 7 | 2023 | 798 | 3.430 |
Why?
|
Kidney Neoplasms | 24 | 2021 | 4229 | 3.210 |
Why?
|
Carcinoma, Renal Cell | 21 | 2021 | 3123 | 3.170 |
Why?
|
Lymphatic Metastasis | 15 | 2022 | 2906 | 2.590 |
Why?
|
Prostatic Neoplasms | 24 | 2023 | 11039 | 2.060 |
Why?
|
Cystectomy | 9 | 2023 | 682 | 2.000 |
Why?
|
Prostate | 11 | 2023 | 1764 | 1.830 |
Why?
|
Lymph Nodes | 8 | 2022 | 3465 | 1.420 |
Why?
|
Prostatectomy | 7 | 2022 | 1871 | 1.390 |
Why?
|
Ureteral Neoplasms | 3 | 2019 | 110 | 1.170 |
Why?
|
Prostate-Specific Antigen | 6 | 2023 | 2458 | 1.060 |
Why?
|
Urology | 2 | 2021 | 397 | 1.010 |
Why?
|
Perioperative Period | 4 | 2019 | 256 | 1.000 |
Why?
|
Urinary Bladder | 6 | 2023 | 1171 | 1.000 |
Why?
|
Witchcraft | 1 | 2022 | 7 | 0.900 |
Why?
|
Neoplasm Staging | 15 | 2023 | 11001 | 0.730 |
Why?
|
Biopsy | 9 | 2023 | 6756 | 0.690 |
Why?
|
Penile Neoplasms | 1 | 2021 | 159 | 0.690 |
Why?
|
Pelvic Organ Prolapse | 2 | 2019 | 134 | 0.690 |
Why?
|
Quality Improvement | 3 | 2018 | 3738 | 0.660 |
Why?
|
Nomograms | 2 | 2021 | 224 | 0.630 |
Why?
|
Colposcopy | 1 | 2018 | 144 | 0.600 |
Why?
|
Renal Insufficiency, Chronic | 3 | 2019 | 2195 | 0.590 |
Why?
|
Postoperative Complications | 8 | 2019 | 15244 | 0.580 |
Why?
|
Gynecologic Surgical Procedures | 2 | 2019 | 336 | 0.520 |
Why?
|
Hospital Costs | 2 | 2018 | 980 | 0.510 |
Why?
|
Urinary Diversion | 1 | 2015 | 137 | 0.500 |
Why?
|
Kidney Calculi | 3 | 2015 | 465 | 0.490 |
Why?
|
Glomerular Filtration Rate | 4 | 2019 | 2167 | 0.490 |
Why?
|
Aged | 43 | 2021 | 162944 | 0.480 |
Why?
|
Male | 61 | 2023 | 349538 | 0.480 |
Why?
|
Retrospective Studies | 32 | 2023 | 77098 | 0.470 |
Why?
|
Middle Aged | 46 | 2023 | 213127 | 0.460 |
Why?
|
Kidney Diseases | 2 | 2017 | 2145 | 0.460 |
Why?
|
Ureteral Diseases | 1 | 2013 | 61 | 0.450 |
Why?
|
Brachytherapy | 1 | 2021 | 1246 | 0.450 |
Why?
|
ABO Blood-Group System | 1 | 2015 | 367 | 0.440 |
Why?
|
Laparoscopy | 4 | 2018 | 2121 | 0.440 |
Why?
|
Neoplasm Invasiveness | 5 | 2022 | 3612 | 0.440 |
Why?
|
Survival Analysis | 5 | 2020 | 10248 | 0.440 |
Why?
|
Humans | 81 | 2023 | 742088 | 0.440 |
Why?
|
Treatment Outcome | 21 | 2023 | 62966 | 0.430 |
Why?
|
Morbidity | 4 | 2018 | 1767 | 0.420 |
Why?
|
Urinary Tract Infections | 3 | 2015 | 786 | 0.410 |
Why?
|
Nephrostomy, Percutaneous | 1 | 2012 | 85 | 0.390 |
Why?
|
Nephrolithiasis | 1 | 2012 | 110 | 0.380 |
Why?
|
Ureter | 1 | 2013 | 374 | 0.370 |
Why?
|
Ureteral Calculi | 1 | 2011 | 110 | 0.370 |
Why?
|
Urolithiasis | 1 | 2012 | 131 | 0.360 |
Why?
|
Risk Assessment | 7 | 2021 | 23320 | 0.360 |
Why?
|
Ureteral Obstruction | 1 | 2011 | 293 | 0.340 |
Why?
|
Databases, Factual | 3 | 2018 | 7716 | 0.330 |
Why?
|
Gonadal Steroid Hormones | 1 | 2013 | 711 | 0.330 |
Why?
|
Length of Stay | 3 | 2018 | 6294 | 0.330 |
Why?
|
Models, Statistical | 3 | 2019 | 5100 | 0.320 |
Why?
|
Proportional Hazards Models | 7 | 2020 | 12344 | 0.300 |
Why?
|
Disease-Free Survival | 7 | 2019 | 6891 | 0.300 |
Why?
|
Ultrasonography, Interventional | 1 | 2015 | 1483 | 0.300 |
Why?
|
Medical Oncology | 1 | 2019 | 2235 | 0.290 |
Why?
|
Animal Nutritional Physiological Phenomena | 1 | 2006 | 57 | 0.290 |
Why?
|
Propensity Score | 3 | 2020 | 1771 | 0.290 |
Why?
|
Female | 39 | 2023 | 379592 | 0.280 |
Why?
|
Survival Rate | 9 | 2022 | 12773 | 0.280 |
Why?
|
Clinical Trials as Topic | 2 | 2021 | 7901 | 0.270 |
Why?
|
Smoking | 1 | 2023 | 8969 | 0.270 |
Why?
|
Attitude of Health Personnel | 2 | 2020 | 3839 | 0.270 |
Why?
|
Retroperitoneal Space | 2 | 2016 | 172 | 0.260 |
Why?
|
Radiology | 1 | 2019 | 2090 | 0.250 |
Why?
|
Prognosis | 9 | 2022 | 29010 | 0.240 |
Why?
|
Combined Modality Therapy | 4 | 2019 | 8621 | 0.230 |
Why?
|
Adult | 22 | 2022 | 213712 | 0.230 |
Why?
|
Early Detection of Cancer | 2 | 2023 | 3070 | 0.230 |
Why?
|
Hospitals | 1 | 2017 | 3937 | 0.220 |
Why?
|
Administration, Intravesical | 1 | 2022 | 91 | 0.220 |
Why?
|
Watchful Waiting | 3 | 2021 | 491 | 0.210 |
Why?
|
Stents | 2 | 2015 | 3276 | 0.210 |
Why?
|
Logistic Models | 5 | 2018 | 13403 | 0.210 |
Why?
|
Organ Size | 3 | 2021 | 2253 | 0.200 |
Why?
|
Inguinal Canal | 1 | 2021 | 69 | 0.190 |
Why?
|
Kidney | 2 | 2021 | 7167 | 0.190 |
Why?
|
Neoadjuvant Therapy | 2 | 2022 | 2721 | 0.190 |
Why?
|
Aged, 80 and over | 9 | 2021 | 57683 | 0.180 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2022 | 3471 | 0.180 |
Why?
|
Circadian Rhythm | 1 | 2012 | 2623 | 0.180 |
Why?
|
Drosophila melanogaster | 2 | 2006 | 1704 | 0.180 |
Why?
|
Drosophila Proteins | 2 | 2006 | 1699 | 0.180 |
Why?
|
Forkhead Transcription Factors | 2 | 2006 | 1613 | 0.180 |
Why?
|
BCG Vaccine | 1 | 2022 | 367 | 0.180 |
Why?
|
Blood Transfusion | 2 | 2017 | 1296 | 0.180 |
Why?
|
United States | 11 | 2023 | 69693 | 0.170 |
Why?
|
Follow-Up Studies | 7 | 2019 | 39004 | 0.170 |
Why?
|
Liver Neoplasms | 1 | 2015 | 4249 | 0.170 |
Why?
|
Young Adult | 9 | 2019 | 56350 | 0.170 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2020 | 9941 | 0.160 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2015 | 9185 | 0.150 |
Why?
|
Prostatic Hyperplasia | 1 | 2021 | 522 | 0.150 |
Why?
|
Urologic Neoplasms | 1 | 2021 | 316 | 0.150 |
Why?
|
Adjuvants, Immunologic | 1 | 2022 | 1000 | 0.150 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2022 | 1769 | 0.150 |
Why?
|
Indocyanine Green | 1 | 2019 | 238 | 0.150 |
Why?
|
Kaplan-Meier Estimate | 3 | 2017 | 6534 | 0.150 |
Why?
|
Tomography, X-Ray Computed | 3 | 2017 | 20086 | 0.140 |
Why?
|
Muscles | 1 | 2022 | 1617 | 0.140 |
Why?
|
Magnetic Resonance Imaging | 5 | 2021 | 35342 | 0.140 |
Why?
|
Evidence-Based Medicine | 2 | 2019 | 3611 | 0.140 |
Why?
|
Cohort Studies | 8 | 2022 | 40450 | 0.140 |
Why?
|
Salvage Therapy | 1 | 2022 | 1269 | 0.140 |
Why?
|
Renal Veins | 1 | 2016 | 108 | 0.130 |
Why?
|
Laparotomy | 1 | 2018 | 474 | 0.130 |
Why?
|
Access to Information | 1 | 2018 | 320 | 0.130 |
Why?
|
Costs and Cost Analysis | 1 | 2021 | 1679 | 0.130 |
Why?
|
Economics, Hospital | 1 | 2017 | 213 | 0.120 |
Why?
|
Intraoperative Care | 2 | 2015 | 766 | 0.120 |
Why?
|
Paraneoplastic Syndromes | 1 | 2016 | 150 | 0.120 |
Why?
|
Ureteroscopy | 1 | 2015 | 142 | 0.120 |
Why?
|
Vagina | 1 | 2019 | 825 | 0.120 |
Why?
|
Adolescent | 6 | 2019 | 85649 | 0.120 |
Why?
|
Risk Factors | 7 | 2018 | 72145 | 0.120 |
Why?
|
Androgen Antagonists | 1 | 2022 | 1350 | 0.120 |
Why?
|
Delivery of Health Care | 3 | 2021 | 5304 | 0.120 |
Why?
|
Incidence | 2 | 2023 | 20928 | 0.120 |
Why?
|
Time Factors | 5 | 2018 | 40054 | 0.110 |
Why?
|
Diabetes Mellitus | 1 | 2012 | 5724 | 0.110 |
Why?
|
Antineoplastic Agents | 2 | 2018 | 13655 | 0.110 |
Why?
|
Vena Cava, Inferior | 1 | 2016 | 436 | 0.110 |
Why?
|
Multivariate Analysis | 2 | 2017 | 12242 | 0.100 |
Why?
|
Urography | 1 | 2013 | 313 | 0.100 |
Why?
|
Molecular Imaging | 1 | 2019 | 831 | 0.100 |
Why?
|
Health Care Surveys | 1 | 2019 | 2451 | 0.100 |
Why?
|
Anxiety Disorders | 1 | 2022 | 2684 | 0.100 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 2013 | 339 | 0.100 |
Why?
|
Lung Neoplasms | 1 | 2015 | 13019 | 0.090 |
Why?
|
Intraoperative Complications | 1 | 2017 | 1188 | 0.090 |
Why?
|
Rupture, Spontaneous | 1 | 2011 | 354 | 0.090 |
Why?
|
Perioperative Care | 1 | 2018 | 997 | 0.090 |
Why?
|
Antibiotic Prophylaxis | 1 | 2015 | 638 | 0.090 |
Why?
|
Practice Guidelines as Topic | 3 | 2020 | 7276 | 0.090 |
Why?
|
Postoperative Care | 1 | 2015 | 1484 | 0.080 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2016 | 933 | 0.080 |
Why?
|
Office Visits | 1 | 2013 | 598 | 0.080 |
Why?
|
Gene Expression Regulation | 1 | 2006 | 12071 | 0.080 |
Why?
|
Anxiety | 1 | 2022 | 4279 | 0.080 |
Why?
|
Reoperation | 1 | 2017 | 4200 | 0.080 |
Why?
|
Decision Making | 2 | 2020 | 3869 | 0.080 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2019 | 3328 | 0.070 |
Why?
|
Pilot Projects | 1 | 2019 | 8297 | 0.070 |
Why?
|
Venous Thrombosis | 1 | 2016 | 1237 | 0.070 |
Why?
|
Prevalence | 1 | 2022 | 15194 | 0.070 |
Why?
|
Yeasts | 1 | 2006 | 285 | 0.070 |
Why?
|
Fat Body | 1 | 2004 | 32 | 0.060 |
Why?
|
Body Mass Index | 1 | 2021 | 12695 | 0.060 |
Why?
|
Sarcoma | 1 | 2015 | 1895 | 0.060 |
Why?
|
Aging | 2 | 2021 | 8626 | 0.060 |
Why?
|
Predictive Value of Tests | 2 | 2019 | 15056 | 0.060 |
Why?
|
Patient Readmission | 1 | 2017 | 3111 | 0.060 |
Why?
|
Disease Management | 1 | 2014 | 2450 | 0.060 |
Why?
|
Disease Progression | 2 | 2017 | 13256 | 0.060 |
Why?
|
Nitrous Oxide | 1 | 2023 | 177 | 0.060 |
Why?
|
Analysis of Variance | 1 | 2012 | 6365 | 0.050 |
Why?
|
Guideline Adherence | 1 | 2013 | 2266 | 0.050 |
Why?
|
Research Design | 1 | 2018 | 5979 | 0.050 |
Why?
|
Thrombosis | 1 | 2016 | 2966 | 0.050 |
Why?
|
Membrane Proteins | 1 | 2019 | 7873 | 0.050 |
Why?
|
Sensitivity and Specificity | 2 | 2019 | 14720 | 0.050 |
Why?
|
Sepsis | 1 | 2015 | 2589 | 0.050 |
Why?
|
Laser Therapy | 1 | 2008 | 1071 | 0.050 |
Why?
|
Insulin | 2 | 2006 | 6575 | 0.050 |
Why?
|
Lidocaine | 1 | 2023 | 542 | 0.050 |
Why?
|
Decision Support Techniques | 2 | 2021 | 1952 | 0.050 |
Why?
|
5-alpha Reductase Inhibitors | 1 | 2021 | 106 | 0.050 |
Why?
|
Venous Thromboembolism | 1 | 2013 | 1668 | 0.050 |
Why?
|
Insurance, Health | 2 | 2023 | 2493 | 0.050 |
Why?
|
Mitochondrial Proteins | 1 | 2006 | 995 | 0.050 |
Why?
|
Cost-Benefit Analysis | 1 | 2013 | 5385 | 0.050 |
Why?
|
Marital Status | 1 | 2022 | 437 | 0.050 |
Why?
|
Mass Screening | 1 | 2016 | 5238 | 0.050 |
Why?
|
Severity of Illness Index | 1 | 2018 | 15530 | 0.050 |
Why?
|
Algorithms | 1 | 2019 | 13853 | 0.040 |
Why?
|
Case-Control Studies | 1 | 2016 | 21719 | 0.040 |
Why?
|
Nephrons | 1 | 2020 | 220 | 0.040 |
Why?
|
Ablation Techniques | 1 | 2021 | 249 | 0.040 |
Why?
|
Insurance | 1 | 2019 | 111 | 0.040 |
Why?
|
Germany | 1 | 2020 | 860 | 0.040 |
Why?
|
Sacrum | 1 | 2019 | 289 | 0.040 |
Why?
|
Anti-Bacterial Agents | 1 | 2015 | 7153 | 0.040 |
Why?
|
Prospective Studies | 3 | 2023 | 53187 | 0.040 |
Why?
|
SEER Program | 1 | 2022 | 1507 | 0.040 |
Why?
|
Anesthetics, Local | 1 | 2023 | 984 | 0.040 |
Why?
|
Longevity | 1 | 2004 | 1069 | 0.030 |
Why?
|
Coloring Agents | 1 | 2019 | 565 | 0.030 |
Why?
|
Technetium | 1 | 2016 | 334 | 0.030 |
Why?
|
Transcription Factors | 2 | 2006 | 12164 | 0.030 |
Why?
|
Neoplasm Metastasis | 2 | 2016 | 4839 | 0.030 |
Why?
|
Energy Metabolism | 1 | 2006 | 2896 | 0.030 |
Why?
|
Age Factors | 1 | 2011 | 18355 | 0.030 |
Why?
|
Europe | 1 | 2021 | 3339 | 0.030 |
Why?
|
Microscopy, Fluorescence | 1 | 2021 | 2699 | 0.030 |
Why?
|
Reproducibility of Results | 1 | 2012 | 19862 | 0.030 |
Why?
|
Urinalysis | 1 | 2015 | 369 | 0.030 |
Why?
|
Child | 1 | 2021 | 77478 | 0.030 |
Why?
|
Oxygen | 1 | 2023 | 4169 | 0.030 |
Why?
|
Injections, Subcutaneous | 1 | 2013 | 664 | 0.030 |
Why?
|
Pelvis | 1 | 2016 | 730 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2006 | 19223 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2006 | 9410 | 0.020 |
Why?
|
Urologic Surgical Procedures | 1 | 2013 | 301 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2023 | 12017 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2019 | 5062 | 0.020 |
Why?
|
Pain | 1 | 2023 | 4961 | 0.020 |
Why?
|
Escherichia coli Infections | 1 | 2011 | 532 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2018 | 2723 | 0.020 |
Why?
|
Lasers, Gas | 1 | 2008 | 93 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2019 | 3564 | 0.020 |
Why?
|
Radiosurgery | 1 | 2016 | 1309 | 0.020 |
Why?
|
Lasers, Solid-State | 1 | 2008 | 169 | 0.020 |
Why?
|
Odds Ratio | 1 | 2017 | 9846 | 0.020 |
Why?
|
Insect Hormones | 1 | 2004 | 75 | 0.020 |
Why?
|
Genes, Insect | 1 | 2004 | 268 | 0.010 |
Why?
|
Immunotherapy | 1 | 2018 | 4414 | 0.010 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2004 | 430 | 0.010 |
Why?
|
Self Report | 1 | 2013 | 3548 | 0.010 |
Why?
|
Healthcare Disparities | 1 | 2017 | 3151 | 0.010 |
Why?
|
Quality of Health Care | 1 | 2017 | 4369 | 0.010 |
Why?
|
Signal Transduction | 1 | 2004 | 23387 | 0.010 |
Why?
|
Societies, Medical | 1 | 2013 | 3740 | 0.010 |
Why?
|
Internet | 1 | 2013 | 3062 | 0.010 |
Why?
|
Receptor, Insulin | 1 | 2004 | 846 | 0.010 |
Why?
|
Organ Specificity | 1 | 2004 | 2003 | 0.010 |
Why?
|
Escherichia coli | 1 | 2011 | 4214 | 0.010 |
Why?
|
PTEN Phosphohydrolase | 1 | 2004 | 1144 | 0.010 |
Why?
|
Brain | 1 | 2004 | 26343 | 0.010 |
Why?
|
Animals | 2 | 2006 | 168561 | 0.010 |
Why?
|
Stress, Physiological | 1 | 2004 | 1402 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2013 | 24913 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2004 | 13029 | 0.010 |
Why?
|
Neurons | 1 | 2004 | 9325 | 0.000 |
Why?
|
Concepts
(239)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(35)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_